Non-syndromic rod-dominant inherited retinal diseases

Clinical trials for Non-syndromic rod-dominant inherited retinal diseases explained in plain language.

Never miss a new study

Get alerted when new Non-syndromic rod-dominant inherited retinal diseases trials appear

Sign up with your email to follow new studies for Non-syndromic rod-dominant inherited retinal diseases, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Experimental eye injection aims to restore sight in rare blindness conditions

Disease control Completed

This study tested an experimental drug called KIO-301, given as an injection into the eye, in 32 adults with retinitis pigmentosa or choroideremia—two inherited conditions that cause progressive vision loss. The main goal was to check safety and tolerability at increasing doses. …

Matched conditions: NON-SYNDROMIC ROD-DOMINANT INHERITED RETINAL DISEASES

Phase 1/2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC

Non-syndromic rod-dominant inherited retinal diseases

Get alerted when new Non-syndromic rod-dominant inherited retinal diseases trials appear

Experimental eye injection aims to restore sight in rare blindness conditions